Welcome to the website of the UK Chemotherapy Partnership – aiming to improve the quality and safety of chemotherapy delivery by sharing information, expertise and opinion. We open the door on the latest developments in chemotherapy service provision and give you access to NHS experts and their documentation to help you develop and improve your own service.

Chemotherapy service

Chemotherapy delivery can be complex and challenging. These are some of the practice innovations and developments within the UK aiming to improve the patient experience.

18
March 2016
Events & meetings

UKCP Systemic-Anti Cancer Therapy Masterclass
Programme to follow.  

CPD

Coming soon. We are very excited to announce this new online educational resource. It will initially include 6 modules on cancer and chemotherapy.

Our videos

Healthcare professionals sharing experiences of service developments, including patient information videos for patients embarking on the treatment pathway.

What's new

Achieving World-Class Outcomes-A Strategy for England 2015-2020

Five year plan to radically improve cancer outcomes.

MORE
2015 ASCO Annual Meeting-Highlights

Highlights from the 2015 ASCO Annual Meeting-Illumination & Innovation; Transforming Data into Learning

MORE
Recovery Package-Cancer Nursing Partnership

The CNP is working to roll out the Recovery Package

MORE
Understanding Cancer E-Learning

Understanding Cancer was launched in April 2012.

MORE

Latest news

'Barcode' tracking of T cells in immunotherapy patients identifies likely cancer

A new discovery by researchers at the Fred Hutchinson Cancer Research Center in Seattle makes an important step in identifying which specific T cells within the diverse army of a person's immune system are best suited to fight cancer. The findings will...

MORE
Daratumumab receives positive CHMP opinion for rrMM

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended broadening the existing marketing authorisation for daratumumab, marketed by Janssen as Darzalex. If approved by the European Commission,...

MORE
CHMP grants positive opinion to dabrafenib and trametinib for BRAF positive NSCLC

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of dabrafenib in combination with trametinib to treat patients with advanced or metastatic non-small...

MORE
Lily-inspired synthetic molecule out-performs chemo in lab tests, targets cancer cell metabolism

A UWindsor research team has targeted and killed 20 varieties of cancer cells using a lab-synthesised drug compound inspired by the common spider lily plant. Chemistry professor Siyaram Pandey says the compound beat out any anti-cancer drug currently in...

MORE
Fasting-mimicking diet may reverse diabetes

A diet designed to imitate the effects of fasting appears to reverse diabetes, a new USC-led study shows. The fasting-like diet promotes the growth of new insulin-producing pancreatic cells that reduce symptoms of type 1 and type 2 diabetes in mice,...

MORE